fda warning letter glp-1 october 2025 Democratic lawmakers are pressing the Trump administration to disclose who received special access to Eli Lilly's investigational obesity drug retatrutide. Sen. Maggie Hassan (D-N.H.) sent a to HHS Secretary Robert F Harnessing GLP-1 Receptor Agonists for

Abstract Osteoarthritis (OA) is a common disabling disease worldwide, with no effective and safe disease-modifying drugs (DMOAD) in the market

How DPP-4 Complicates Measuring GLP-1 Accurately Chemi Active GLP-1 (7-36) amide ELISA

However, users need to know before they start a GLP-1 that taking these medications is not effortless

Since not all pregnancies are planned, more and more people were becoming pregnant while being treated with these drugs. Nowadays, GLP-1 receptor agonists such as Therefore, an increasing number of patients and healthcare providers will be looking for information on the safety of GLP-1 receptor agonists when used early in pregnancy

Use of GLP-1 medications for weight loss has nearly quadrupled among adults in the United States in the past two years, rising from 3% in 2024 to 11%, according to figures cited in new report by EPIC Research